SPIA
SCLN

Steward Partners Investment Advisory’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Steward Partners Investment Advisory’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-250
Closed -$2K – 2024
2017
Q3 		$2K Hold
250
– – ﹤0.01% 1560
2017
Q2 		$2K Hold
250
– – ﹤0.01% 1481
2017
Q1 		$2K Buy
+250
New +$2.5K ﹤0.01% 1359

Steward Partners Investment Advisory's SCLN Position: Q4 2017 in Review

Steward Partners Investment Advisory sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 250 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in SCLN in Q1 2017 and held it in 3 quarters. The position peaked at $2K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Steward Partners Investment Advisory reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 250 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $2K.
  • Steward Partners Investment Advisory first reported a position in Sciclone Pharmaceuticals Inc in Q1 2017 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Sciclone Pharmaceuticals Inc position peaked at $2K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2017, filed 19 Jan 2018.